5 - 8 of 147 news items
As the world attempts to deal with the COVID-19 pandemic, clinicians and scientists around the world, including our own at the Trust, are working around the clock to find effective treatments. Several COVID-19 research studies have been approved and are actively recruiting across both hospitals. Some will be testing existing treatments that are already in use for other diseases, others will involve determining any genetic variation between patients and how this affects the development of the disease. Read more.
People who have been identified as extremely vulnerable to coronavirus (COVID-19) have been asked to ‘shield’ – that is to not leave their home and minimise all face-to-face contact with other people. If you have had an organ transplant, have a severe respiratory or cardiac condition, or are on immunosuppression therapy, you are included in this group. People who are shielding can get particular help and support. Read more.
A new virtual communication system has been set up in just fourteen days to give frontline teams treating patients with coronavirus at Royal Brompton and Harefield hospitals, round-the-clock remote access to specialist colleagues at the Trust. The system will also enable some family members of critically ill patients to see and speak to their loved ones. Read more
People who have been identified by the NHS as being at higher risk of severe illness if they contract coronavirus (COVID-19) will be sent a letter asking them to stay at home for 12 weeks in order to protect themselves. People in this high-risk group are considered extremely vulnerable due to their serious and long-term health conditions. Read more.